A longitudinal study assessing differences in causes of death among housed and homeless people diagnosed with HIV in San Francisco.
Cause of death
HIV
Homeless
Housing
Mental health
Mortality
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
01 Nov 2019
01 Nov 2019
Historique:
received:
16
07
2019
accepted:
21
10
2019
entrez:
3
11
2019
pubmed:
5
11
2019
medline:
18
1
2020
Statut:
epublish
Résumé
San Francisco has implemented several programs addressing the needs of two large vulnerable populations: people living with HIV and those who are homeless. Assessment of these programs on health outcomes is paramount for reducing preventable deaths. Individuals diagnosed with HIV/AIDS and reported to the San Francisco Department of Public Health HIV surveillance registry, ages 13 years or older, who resided in San Francisco at the time of diagnosis, and who died between January 1, 2002, and December 31, 2016 were included in this longitudinal study. The primary independent variable was housing status, dichotomized as ever homeless since diagnosed with HIV, and the dependent variables were disease-specific causes of death, as noted on the death certificate. The Cochran-Armitage test measured changes in the mortality rates over time and unadjusted and adjusted Poisson regression models measured prevalence ratios (PR) and 95% confidence intervals (CI) for causes of death. A total of 4158 deceased individuals were included in the analyses: the majority were male (87%), ages 40-59 years old at the time of death (64%), non-Hispanic White (60%), men who have sex with men (54%), had an AIDS diagnosis prior to death (87%), and San Francisco residents at the time of death (63%). Compared to those who were housed, those who were homeless were more likely to be younger at time of death, African American, have a history of injecting drugs, female or transgender, and were living below the poverty level (all p values < 0.0001). Among decedents who were SF residents at the time of death, there were declines in the proportion of deaths due to AIDS-defining conditions (p < 0.05) and increases in accidents, cardiomyopathy, heart disease, ischemic disease, non-AIDS cancers, and drug overdoses (p < 0.05). After adjustment, deaths due to mental disorders (aPR = 1.63, 95% CI 1.24, 2.14) were more likely and deaths due to non-AIDS cancers (aPR = 0.63, 95% CI 0.44, 0.89) were less likely among those experiencing homelessness. Additional efforts are needed to improve mental health services to homeless people with HIV and prevent mental-health related mortality.
Sections du résumé
BACKGROUND
BACKGROUND
San Francisco has implemented several programs addressing the needs of two large vulnerable populations: people living with HIV and those who are homeless. Assessment of these programs on health outcomes is paramount for reducing preventable deaths.
METHODS
METHODS
Individuals diagnosed with HIV/AIDS and reported to the San Francisco Department of Public Health HIV surveillance registry, ages 13 years or older, who resided in San Francisco at the time of diagnosis, and who died between January 1, 2002, and December 31, 2016 were included in this longitudinal study. The primary independent variable was housing status, dichotomized as ever homeless since diagnosed with HIV, and the dependent variables were disease-specific causes of death, as noted on the death certificate. The Cochran-Armitage test measured changes in the mortality rates over time and unadjusted and adjusted Poisson regression models measured prevalence ratios (PR) and 95% confidence intervals (CI) for causes of death.
RESULTS
RESULTS
A total of 4158 deceased individuals were included in the analyses: the majority were male (87%), ages 40-59 years old at the time of death (64%), non-Hispanic White (60%), men who have sex with men (54%), had an AIDS diagnosis prior to death (87%), and San Francisco residents at the time of death (63%). Compared to those who were housed, those who were homeless were more likely to be younger at time of death, African American, have a history of injecting drugs, female or transgender, and were living below the poverty level (all p values < 0.0001). Among decedents who were SF residents at the time of death, there were declines in the proportion of deaths due to AIDS-defining conditions (p < 0.05) and increases in accidents, cardiomyopathy, heart disease, ischemic disease, non-AIDS cancers, and drug overdoses (p < 0.05). After adjustment, deaths due to mental disorders (aPR = 1.63, 95% CI 1.24, 2.14) were more likely and deaths due to non-AIDS cancers (aPR = 0.63, 95% CI 0.44, 0.89) were less likely among those experiencing homelessness.
CONCLUSIONS
CONCLUSIONS
Additional efforts are needed to improve mental health services to homeless people with HIV and prevent mental-health related mortality.
Identifiants
pubmed: 31675932
doi: 10.1186/s12889-019-7817-7
pii: 10.1186/s12889-019-7817-7
pmc: PMC6825332
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1440Subventions
Organisme : CDC HHS
ID : SU62PS004022-04
Pays : United States
Références
AIDS Care. 2004 Feb;16(2):199-211
pubmed: 14676026
J Acquir Immune Defic Syndr. 2009 Dec;52(5):611-22
pubmed: 19770804
AIDS. 2009 Aug 24;23(13):1791-2
pubmed: 19684484
AIDS Behav. 2019 Mar;23(3):776-783
pubmed: 30684098
BMC Public Health. 2009 Jul 07;9:220
pubmed: 19583862
Lancet. 2007 Jul 7;370(9581):59-67
pubmed: 17617273
Curr HIV/AIDS Rep. 2012 Dec;9(4):364-74
pubmed: 22968432
JAMA. 2019 Mar 5;321(9):844-845
pubmed: 30730529
AIDS Care. 2016;28(1):98-103
pubmed: 26273965
Arch Intern Med. 2001 Jan 22;161(2):277-84
pubmed: 11176744
MMWR Recomm Rep. 2014 Apr 11;63(RR-03):1-10
pubmed: 24717910
JAMA. 1998 Aug 12;280(6):547-9
pubmed: 9707146
J Health Care Poor Underserved. 2015 Aug;26(3):1005-18
pubmed: 26320929
J Acquir Immune Defic Syndr. 2006 Jul;42(3):298-306
pubmed: 16639343
N Engl J Med. 1994 Aug 4;331(5):304-9
pubmed: 8022442
Am J Psychiatry. 2005 Feb;162(2):370-6
pubmed: 15677603
JAMA Intern Med. 2013 Feb 11;173(3):189-95
pubmed: 23318302
Public Health Rep. 2017 Nov/Dec;132(6):669-675
pubmed: 29091542
Ann Intern Med. 2008 May 20;148(10):728-36
pubmed: 18490686
Am J Public Health. 1999 Apr;89(4):529-34
pubmed: 10191796
AIDS Behav. 2007 Nov;11(6 Suppl):85-100
pubmed: 17682940
Drugs. 2006;66(6):769-89
pubmed: 16706551
AIDS. 2007 Mar 30;21(6):685-92
pubmed: 17413689
AIDS Behav. 2015 Aug;19(8):1491-500
pubmed: 25931243
Am J Addict. 2005 May-Jun;14(3):195-207
pubmed: 16019970
J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):529-37
pubmed: 26569177
Am J Public Health. 2009 Nov;99 Suppl 3:S675-80
pubmed: 19372524
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):96-103
pubmed: 15608532
JAMA. 2007 Mar 14;297(10):1061-2
pubmed: 17356026
AIDS. 2009 Nov 13;23(17):2337-45
pubmed: 19741479
Open Forum Infect Dis. 2018 Mar 14;5(3):ofy035
pubmed: 29577059
Arch Gen Psychiatry. 2001 Aug;58(8):721-8
pubmed: 11483137